LigaChem Biosciences Inc. (KOSDAQ:141080)

LigaChem Biosciences Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019
Period Ending	Apr 1, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2019
Market Capitalization	7,481,254	3,975,267	1,827,289	1,092,804	1,352,308	566,118
Market Cap Growth	84.76%	117.55%	67.21%	-19.19%	138.87%	-5.72%
Enterprise Value	6,944,703	3,458,030	1,723,146	929,358	1,262,535	481,684
Last Close Price	205500.00	109000.00	65000.00	42850.00	55800.00	26400.00
PE Ratio	-	509.64	-	-	-	41.67
Forward PE	-	44.50	44.50	44.50	44.50	-
PS Ratio	46.97	31.58	53.52	32.71	42.05	9.85
PB Ratio	13.29	6.45	12.33	4.98	5.23	4.88
P/TBV Ratio	14.54	6.54	12.94	5.19	5.44	5.44
P/FCF Ratio	-	52.41	-	-	-	27.29
P/OCF Ratio	-	50.66	-	-	-	23.48
EV/Sales Ratio	43.60	27.47	50.47	27.82	39.26	8.38
EV/EBITDA Ratio	-	-	-	-	-	39.22
EV/EBIT Ratio	-	-	-	-	-	57.23
EV/FCF Ratio	-176.63	45.59	-	-	-	23.22
Debt / Equity Ratio	0.01	0.00	0.09	0.06	0.05	0.02
Debt / EBITDA Ratio	-	-	-	-	-	0.18
Debt / FCF Ratio	-	0.01	-	-	-	0.11
Net Debt / Equity Ratio	-0.97	-0.80	-0.59	-0.72	-0.65	-0.80
Net Debt / EBITDA Ratio	13.21	31.01	1.15	3.41	6.84	-7.54
Net Debt / FCF Ratio	13.88	-6.50	1.37	13.96	2.79	-4.46
Asset Turnover	0.22	0.27	0.15	0.12	-	0.44
Inventory Turnover	87.50	77.94	82.64	66.32	-	16.35
Quick Ratio	8.63	4.46	3.21	6.61	13.35	6.90
Current Ratio	8.97	4.70	3.63	6.70	13.45	7.22
Return on Equity (ROE)	-5.39%	2.04%	-40.08%	-18.85%	-	11.28%
Return on Assets (ROA)	-4.12%	-2.82%	-22.86%	-11.54%	-	4.00%
Return on Invested Capital (ROIC)	-954.15%	-19.45%	-131.59%	-66.23%	-48.80%	26.99%
Return on Capital Employed (ROCE)	-7.40%	-3.40%	-53.00%	-22.50%	-10.00%	6.70%
Earnings Yield	-0.34%	0.20%	-4.03%	-4.13%	-1.73%	2.40%
FCF Yield	-0.53%	1.91%	-3.48%	-1.03%	-4.46%	3.66%
Buyback Yield / Dilution	-7.20%	-22.36%	-1.38%	-16.13%	-0.47%	-13.94%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.